RO7795081
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for RO7795081, covering 2025-07-08 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity [Phase 2]